Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | ACACA | Q13085 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30632580 | 0.87 | TSHR (0.34) | TET2ALDH1A1ACACBACACABLM | |
| SCHEMBL29220621 | 0.82 | CA1 (0.46) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL2033747 | 0.82 | TET2 (0.41) | TET2CA1ALDH1A1KMT2AACACB | |
| SCHEMBL28034 | 0.82 | CA1 (0.46) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL30090581 | 0.78 | TET2 (0.35) | TET2TDP1LMNAALDH1A1HSD17B10 | |
| SCHEMBL29375157 | 0.75 | ALDH1A1 (0.40) | TET2TDP1ALDH1A1 | |
| SCHEMBL30307791 | 0.75 | ACACB (0.40) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL29619472 | 0.74 | NAAA (0.40) | LMNA | |
| SCHEMBL4735967 | 0.73 | NAAA (0.42) | — | |
| SCHEMBL30341731 | 0.73 | NAAA (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117957488-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | 日产化学株式会社 | 2024-04-30 | — | — | CN | disclosed |
| CN-117089418-A | Substrate treatment composition and substrate treatment method using same | SK株式会社 | 2023-11-21 | — | — | CN | disclosed |
| CN-117025316-A | Substrate treatment composition and substrate treatment method using same | SK株式会社 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023032753-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2023-03-09 | — | — | WO | disclosed |
| US-11366386-B2 | Patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11366386-B2 | Patterning process | FEM1B, EGLN1, TET1 | TET2 16/4885CA12 573/4885CA1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.